Experimental data showed that ANXA7 may function to aggravate brain damage via affecting glutamate release, inducing neuronal apoptosis, disrupting the blood–brain barrier, and increasing brain edema, thereby worsening neurological function after traumatic brain injury (11), ICH (12), and subarachnoid hemorrhage (13). Here, ANXA7 is linked to subarachnoid hemorrhage.